Main menu button

Herantis Pharma at Carlsquare Nordic life science investor day

Equity Research
28 Nov 2022

Antti Vuolanto, CEO at Herantis Pharma, presented at Carlsquare Nordic Life Science Investor Day on November 17 2022.

Herantis Pharma at Carlsquare Nordic life science investor day

Similar News

Equity research White Pearl Technology Group: Upgraded revenue guidance supports the investment case
30 Sep 2025
Equity research White Pearl Technology Group: Upgraded revenue guidance supports the investment case
Equity Research White Pearl Technology Group
Equity research Immunovia: PancreaSure launch in the US is underway
26 Sep 2025
Equity research Immunovia: PancreaSure launch in the US is underway
Equity Research Immunovia
Equity research Viva Wine Group: Process to transfer to the Main list initiated
24 Sep 2025
Equity research Viva Wine Group: Process to transfer to the Main list initiated
Equity Research Viva Wine Group
Equity research CDON: Moderate capital raise, profitability improving in Q3
19 Sep 2025
Equity research CDON: Moderate capital raise, profitability improving in Q3
Equity Research CDON
Equity Research Biosergen: Candidozyma auris on the rise in Europe
17 Sep 2025
Equity Research Biosergen: Candidozyma auris on the rise in Europe
Equity Research Biosergen